EcoR1 Capital
GOSS icon

EcoR1 Capital’s Gossamer Bio GOSS Stock Holding History

EcoR1 Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-114,943
Closed -$10.9M – 58
2024
Q1 		$10.9M Hold
114,943
– – 0.27% 44
2023
Q4 		$8.39M Hold
114,943
– – 0.22% 35
2023
Q3 		$7.66M Buy
+114,943
New +$10.6M 0.26% 36
2022
Q4 		– Sell
-52,011
Closed -$49.8M – 70
2022
Q3 		$49.8M Buy
+52,011
New +$51.6M 1.47% 15
2021
Q1 		– Sell
-3,678
Closed -$2.84M – 77
2020
Q4 		$2.84M Buy
+3,678
New +$2.9M 0.15% 48
2019
Q3 		– Sell
-9,651
Closed -$15.4M – 40
2019
Q2 		$17.1M Hold
9,651
– – 1.73% 16
2019
Q1 		$16.7M Buy
+9,651
New +$16.1M 1.54% 19

Other funds holding GOSS

NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Palo Alto Investors
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Samsara BioCapital
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EcoR1 Capital's GOSS Position: Q2 2024 in Review

EcoR1 Capital sold out of Gossamer Bio (GOSS) in Q2 2024, closing a stake of 114,943 shares — an estimated $10.9M sold.

EcoR1 Capital first reported a position in GOSS in Q1 2019 and held it in 7 quarters. The position peaked at $49.8M in Q3 2022. 93 funds tracked by Wall St. Rank hold GOSS as of Q2 2024.

  • EcoR1 Capital reported no remaining Gossamer Bio position as of Q2 2024 after selling out during the quarter.
  • EcoR1 Capital sold 114,943 Gossamer Bio shares in Q2 2024, an estimated $10.9M.
  • EcoR1 Capital first reported a position in Gossamer Bio in Q1 2019 and held it in 7 quarters.
  • EcoR1 Capital's Gossamer Bio position peaked at $49.8M in Q3 2022.
  • 93 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2024.

Based on EcoR1 Capital's 13F filing for Q2 2024, filed 14 Aug 2024.